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Abstract The vast majority of stent thrombosis occurs in the acute and sub-acute phases and is more 
common in patients with acute coronary syndromes, due to the thrombotic milieu where stent struts are 
positioned. Stent thrombosis is likely due to incomplete tissue coverage of metallic stents as the 
contact between metallic stents and blood elements may lead to platelet adhesion and trigger vessel 
thrombosis. If a stent is covered after 7 days, the risk that it will be found uncovered at later stages is very 
low (<1 %). In this article, we demonstrate that diamond-like carbon (DLC) coatings, deposited by physical 
vapour deposition, promote rapid endothelisation of coronary stent devices, with very low platelets 
activation, reducing thrombotic clots. We relate these behaviours to the surface and bulk material 
properties of the DLC films, subjected to a comprehensive chemico-physical characterisation using 
several techniques (X-ray photoelectron spectroscopy, atomic force microscopy, field-emission 
scanning electron microscope, transmission electron microscopy combined with electron energy loss 
spectroscopy, Raman and dispersive X- ray spectroscopy). In vivo studies, conducted on 24 pigs, have 
shown complete endothelisation after 7 days, with no fibrin mesh and with only rare monocytes scattered 
on the endothelial layer while 30 and 180 days tests have shown reduced inflammatory activation and a 
complete stabilisation of the vessel healing, with a minimal neointimal proliferation. The integral and 
permanent DLC film coating improves haemo- and bio-compatibility and leads to an excellent early 
vessel healing of the stent whilst the extremely thin strut thickness reduces the amount of late neointima 
and consequently the risk of late restenosis. These data should translate into a reduced acute and sub-
acute stent thrombosis. 
 
Keywords Biomaterials Interface/surface analysis Thin films X-ray spectroscopy (XPS/XRF/EDX) 
Atomic force microscopy (AFM) Electron/ion microprobe 
 
 
Introduction 
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Every time a foreign body comes into contact with a human corpus, the response of the immune 
defence system is proportional to the alarm bell that has been activated. Nevertheless, it is 
sometimes necessary to include foreign materials inside human organs and tissues, in order to 
solve health problems. This happens, for instance, when we are dealing with cardiovascular 
diseases, which are tackled mainly by implanting valves and/or coronary stents. For this reason, after 
having chosen the best shape and size, in order to be as little invasive as possible, it is necessary to 
focus on the type of material that can be the best solution to mimic body tissue, to prevent 
inflammations and not be rejected. Literature [1, 2] shows that such materials have to fulfil several 
requirements, such as to possess appropriate mechanical properties and surface characteristics, 
excellent haemocompatibility and good biocompatibility. Carbon- based materials have been 
considered, in the last decades, as one of the most biocompatible compounds, and they have been used 
as coating materials for bare metallic structures since they are chemically inert and they can reduce 
metal- ion release from the inner substrates [3]. Among all the carbon allotropes, diamond-like 
carbon (DLC) has high hardness, low friction coefficient, low wear rate, strong adhesion to the 
substrate and a smooth surface finishing [4, 5]. These properties make it ideal as a coating for 
cardiovascular (heart valves and peripheral stents), orthopaedic and dental applications [6–8]. The 
remarkable properties of DLC derive from its amorphous atomic structure, and the ratio of sp2- to 
sp3-bonded carbon, that is strongly correlated with the deposition technique used. Such techniques 
fall into two broad categories, depending on whether the process is primarily chemical or physical. 
For the first category chemical vapour deposition (CVD) is the most utilised, while for the second 
one the possibilities are multiples, including ion beam deposition, filtered cathodic vacuum arc 
deposition, DC and RF sputtering, pulsed laser deposition, and plasma immersion ion 
implantation [9, 10]. Moreover, deposition at low temperatures allow the growth of DLC thin films 
onto temperature-sensitive substrates, like polymers and metals with low melting points [11]. In 
order to be sure about DLC biocompatibility, several studies have been accomplished on various forms 
of these carbon films, from blood compatibility [12, 13] to cell activity and cytotoxic effects 
surveys, with several cell culture lines [14, 15]. A low degree of platelets spread out on DLC-coated 
medical devices has been associated with a low degree of roughness and a hydrophobic behaviour of 
the surface [16]. Furthermore, it has been proved that DLC thin films can prolong the clotting time, 
suppress the plate- lets and complement convertase activation, when compared with reference polymer 
substrates or Si wafers [17]. Another important aspect is the non-activation of inflammatory signals 
that can produce pathological responses to the implants such as the formation of blood clots [18, 
19]. Previous investigations of DLC as a biomaterial have focused mainly on the biological 
performance of DLC coatings by means of cell cultures or cytotoxicity studies [20, 21], without a 
detailed understanding of the composition and structural effects of the coating for specific 
biomedical applications. Recently, the attention has been focused mainly on the characterisation of 
the DLC surface, in order to propose an explanation about the relationship between the physico-
chemical properties of the surface of DLCs and the biological response [22, 23]. In this outlook, our 
scope is to provide an extensive characterisation of a DLC coating (iCarbofilm™), deposited on cobalt 
chromium alloy coronary stents. For this reason, we investigate the surface and bulk physical properties of 
the DLC, as well as the pro-healing effect, based on two biological response parameters, rapid 
endothelisation and long-term inflammatory responses. 
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Materials and methods 
 
Materials 
 
Twenty-six Avantgarde™ stents, manufactured by CID S.p.A. (Saluggia, VC, Italy), were prepared to 
assess both the physical properties of the carbon-coated stent surfaces and the pro- healing effect, by 
means of implantation in porcine native coronary arteries. The Avantgarde™ stent is a cobalt–chromi- 
um (Co–Cr; L605) alloy stent, coated with a thin film (<0.3 µm) of high-density pure carbon. 
All Avantgarde™ stents were mirror-like polished and cleaned prior to coating. The carbon film 
(iCarbofilm™) was deposited on the stent surface by means of a physical vapour deposition (PVD) at 
low temperatures (T<100 °C) resulting in a very high adhesion force to the alloy substrate (>70 MPa), 
as measured with the pulling test (ASTM D4541 and ISO4624). Two Avantgarde™ stents, reduced in 
small pieces (<5 mm) using sharp surgical scissors, were dedicated to chemico-physical examinations, 
while the remaining 24 were implanted in porcine coronary arteries for in vivo assessment of 
endothelisation at 7 days and tissue inflammatory response at 30 and 180 days. Avantgarde™ stents 
were compared with 24 clinical grade Co–Cr stents (Multi-Link Vision, Abbott Vascular Laboratories, 
USA), used as the control group. 
 
Coating characterisation 
 
X-ray photoelectron spectroscopy 
 
A Thermo Scientific Sigma Probe X-ray photoelectron spec- troscopy (XPS) instrument, equipped with 
a monochromatic Al X-ray source (1486.6 eV energy, 15 kV voltage and 1 mA anode current), has been 
used to investigate surface chemical composition and carbon allotrope state of the DLC thin film. A spot 
size of 100 µm has been used in order to collect the signal only from the coated stent structure. Different 
pass energy values have been used for the various types of spectra acquisition: 300 eV for survey 
spectra, 50 eV for C1s peak, 100 eV for the valence band (VB) region and 20 eV for the O1s peak. 
 
Field emission scanning electron microscope combined with energy-dispersive X-ray spectroscopy 
 
A ZEISS SUPRA 40 field-emission scanning electron microscope (FESEM) has been used to 
analyse the sample surface, to check its roughness and morphology. As the sample was 
conducting, no special charge suppression was necessary. An OXFORD INCA ENERGY 450 
energy-dispersive X-ray spectroscopy (EDX), equipped with a liquid-nitrogen cooled Si(Li) 
detector (with guaranteed resolution of 133 eV at MnKα, 70 eV at FKα and 66 eV at CKα), has 
been used to obtain information regarding the DLC film chemical composition. 
 
Raman spectroscopy 
 
The Raman spectra were recorded using a Renishaw inVia confocal Raman spectrometer coupled to a 
Leica microscope with a ×50 objective in backscattering geometry. We used two laser wavelengths for 
analysis, 514 and 458 nm, produced using an argon–krypton laser with a holographic notch filter with a 
grating of 1,800 lines/mm for 514 nm line and 2,400 lines/mm for the 458 nm one. The backscattered 
Raman photons were collected by a thermoelectrically cooled (-60°C) CCD detector. The scattering 
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spectra were recorded in the range of 0–3,500 cm−1, in one acquisition, 30 s accumulation time and 0.7 
mW beam intensity at the sample surface. 
 
Atomic force microscopy 
 
The film surface morphology has been investigated in ambient atmosphere with a Digital Instruments 
NanoScope IIIa atomic force microscope (AFM), operating in tapping mode, using NanoScope 
Software 6.1 version. Each small piece obtained from cutting the stent, was attached with a strong 
adhesive tape to a sample holder, in order to hold it firmly during the tip scan. 
 
Transmission electron microscopy combined with electron energy loss spectroscopy 
 
The sp2/sp3 bond ratio of the DLC coating was measured using a Philips CM200 transmission 
electron microscopy (TEM; LaB6 filament, 200 kV accelerating voltage) fitted with a Gatan 
Imaging Filter (GIF; 2000 with a 1 × 1 K charge-coupled device), which allows for electron energy 
loss spectroscopy (EELS). A carbon film portion has been detached mechanically from each sample 
by lapping the metal part by means of fine-grit sandpaper. 
 
In vivo studies 
 
The tests were conducted on 24 pigs. All animals were randomly implanted with one Avantgarde 
and one control stent (right coronary artery and left-descending anterior coronary artery). They were 
anaesthetised and treated with antibiotics, then heparinised (150 UI/kg) by intra-arterial route 
(ACT>300 s). An arterial access was made in the common right carotid artery by means of a 7 F 
introducer. A Judkins or Amplaz type guide catheter was inserted through the introducer by 
means of a J guide wire, size 0.035 in. The coronary ostium was reached with injection of contrast 
media. The investigational devices were implanted through a 6-F guide catheter over a 0.014-
in. guide wire. The operation was monitored by angiography; the device was driven until the 
implantation site was reached, then it was expanded by appropriate pressure (vessel/device diameter 
ratio of 1:1.1) until it was well apposed to the vessel wall. The antiplatelet treatment was limited to 
aspirin from 2 days before the procedure to the seventh post- procedural day, then suspended. No 
supplementary antiplatelet drugs (ticlopidine or clopidogrel) were administered. At the end of the 
prescribed follow-up period, all animals underwent a further angiographic examination in order to 
assess the vessel patency. The animals were anesthetised with intramuscular injections of 2 mg/kg of 
ketamine and 2 mg/kg of xylazine and by inhaling 1 % isofluoran. A 7-F introducer was positioned in 
the left carotid artery and a follow-up angiography was carried out on the implanted coronaries, 
using a similar method to the one described above. The animals received 14,000 IU of 
intravenously administered heparin. The animals were then euthanised by an intravenous injection 
of barbiturate (60 mg/kg) through the jugular access, following the ‘AVMA guidelines on Euthanasia 
(June 2007)’. After the explants, the heart was submitted to X-ray analysis to confirm the stent 
location, following which the coronary trees were perfused with heparinised physiological solution. 
When the perfused liquid looked free from haematic traces, the coronaries were fixed with a solution 
of formaldehyde at 4 % at 150 mmHg pressure. The coronary vessels were then carefully dissected from 
the epicardial surface, preserving the artery size and shape. Then the samples were formalin post-
fixed. The stents explanted at 7 days were processed for scanning electron microscopy (SEM) to 
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assess endothelisation. Stent segments for SEM analysis were longitudinally cut, critical point dried 
and, before gold coating, pictures were taken of each half-stent by a stereo microscope at high 
magnification. After the gold coating (5 nm), which was necessary because the stent surface covered 
by the endothelium was no longer conductive, the stent segments were analysed by SEM at ×35 and 
×250 magnification (or higher if necessary), to observe the surface of the stent. Endothelisation was 
calculated from the stereoscopic images by measuring the non-endothelised strut surfaces, over the 
total extent of strut surfaces. The stented coronary segments at 30 and 180 days were tested for 
methyl-methacrylate embedding. A representative number of 5 µm sections were cut perpendicularly 
to the long axis of the vessel by a precision microtome, at the proximal, mid- and distal stent 
level. Histological sections were stained with haematoxylin and eosin and Movat Pentachromic. 
Photomicrographs were taken for each segment of interest, in order to process for histological and 
histomorphometric analysis. Endothelisa- tion percentage and histomorphometric variables were mea- 
sured and analysed by Image-Pro Plus software (Media Cybernetics Inc. Bethesda, MD). 
 
 
 
Fig. 1 XPS C1s peak 
high-resolution spectrum 
showing the 
deconvolution made with 
three Voigt functions, 
which give the 
contribution of the sp2, 
sp3 and C–O chemical 
shifts. DLC VB spectrum 
has been reported in the 
inset, together with a 
diamond reference 
spectrum taken from [32], 
showing the absence of 
the diamond fingerprint 
peak at 13 eV (peak II) 
 
 
Results and discussion 
 
Stent analysis pre-implantation 
 
In order to understand how the growth parameters affected the film morphology and its biocompatible 
behaviour, first of all we have conducted a complete surface and bulk characterisation of the DLC 
film [24]. We performed XPS analysis on two different locations, for both surfaces (inner and outer) 
of the stents. Survey spectra show two main photoelectronic peaks at 531 (O1s) and 285 eV (C1s) 
and Auger peaks at 1,000 eV (O KLL). We detected also some small peaks indicating surface 
contamination (N, Fe, Na, Si and Cl). Relative atomic concentration has been evaluated after 
subtracting the background with a Shirley function [25] obtaining ∼15–20 % for O1s and less than 3 
% for the contaminants. C1s high-resolution spectra (see Fig. 1) have been decomposed, using three 
Voigt-shaped components, in order to evaluate sp2/sp3 ratio. After an exhaustive research in literature 
[26–29], we attributed the three peaks to the following carbon bonds: 284.2–284.5 eV to sp2 
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component; 285.2–285.6 eV to sp3-bonded carbon and 286.1–288.1 eV to chemical shifts due to C–O 
bonds (C–O–C, C0O etc.). The sp3 amount is roughly constant (from 35.4 to 39.7 %) in all investigated 
locations. This can be attributed to a chemically homogeneous surface characterised by regions 
which do not differ very much. 
It is interesting to note that, in the case of amorphous carbon materials that have both sp2 and sp3 
atoms, the study of the C1s spectrum can be supported focusing the attention onto another region of 
the XPS spectrum: the VB [30, 31]. 
 
 
 
Fig. 2 The FESEM images of the stent inner (A) and outer (B) side, showing the cauliflower structures due to the 
microstructures and the small round shapes due to the nanostructures 
 
 
 
 
Fig. 3 AFM maps taken at 
two scan range, 3.3 ×3.3 
µm2 (A) and 370× 370 
nm2 (B). The first one 
shows the uniformity of 
the grains distribution, 
while the second one 
shows the bigger and 
smaller structures, as 
shown by FESEM 
 
 
 
 
 
 
 
 
 
McFeely et al. [32] have conducted an accurate study to this purpose, analysing the diamond, graphite 
and amorphous carbon VB. It is possible to distinguish three main features: a moderately broad and 
intense peak in the range between 15 and 21 eV (peak I), a less-intense peak between 10 and 15 eV 
(peak II) and a broad and less-defined structure, extending from 10 to 13 eV to the cut-off energy 
(peak III). The VB arise predominantly from 2s and 2p atomic states. The intensity of peak I is 
greater than peak III one mainly due to the large difference in the photoemission cross-section ratio 
as σð2sÞ=σð2pÞ ¼ 13 [33]. Since peak II is negligible in graphite and amorphous carbon VB spectra, 
we conclude that it is due to sp3 hybrids bonds. In our stent VB spectrum (see Fig. 1 inset), the three 
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peaks (I, II and III) are not so evident and the overall spectrum is similar to the glassy carbon VB 
reported by McFeely [32]. The presence of the O2s peak at 26 eV makes a full decompo- sition of 
the signal quite unreliable because of the overlap between it and peak I. Hence, an estimate of 
sp2/sp3 ratio from this spectrum will be affected by a very large error bar. 
To further test our coatings’ surfaces, FESEM, combined with EDX, was used to detect the surface 
micro morphology (see Fig. 2) and bulk chemical composition [34]. We can observe two types of 
micro and nanostructures: the first are ‘cauliflower like’ and their  average dimensions vary 
depending on the location on the stent (from 20 to 60 nm on inner and from 50 to 120 nm on outer 
surfaces) while the latter appear to be constant (around 6 nm) independently from side and zone. 
EDX spectra have shown the presence of several chemical elements, apart from C and O, (Co, Fe, Ni, 
W and Cr) which correspond to the L605 alloy chemical composition. 
 
Table 1 Raman Id/Ig ratios calculated for inside and outside scanned areas and grain sizes calculated via 
Tuinstra formula [37], with their relative errors (σ) 
 
Surface   Id/Ig   σ (Id/Ig)   La (nm)   σ (La; nm) 
Inside    1.45   ±0.04    3.00    ±0.08 
Outside   1.26   ±0.15    3.5    ±0.4 
 
 
FESEM results have been confirmed by AFM analysis (see Fig. 3), which displayed the same bigger 
and smaller structures, already found in the FESEM scans. AFM maps have shown also an average 
roughness (RMS) which goes from 2.7 ± 0.2 nm for the bigger scan range (3.3 ×3.3 µm2) to 1.6 ± 
0.4 nm for the smallest one (370 ×370 nm2) [35]. This indicates that the film surface is mostly 
uniform, without significant variations in grains dimensions, all along the coating. To investigate the DLC 
film's morphology and sp2/sp3 bonding beyond the surface, we use two additional techniques: Raman 
spectroscopy and TEM, this last combined with EELS. The first is a well-known technique providing 
information about carbon allotropes kind and crystalline structure dimensions [36]. Using the 514-nm 
laser line excitation, we evaluated the Id/Ig ratio for each stent zone (inside and outside). This ratio is 
correlated with the grain size, using the Tuinstra–Koening formula: Id=Ig ¼ CðlÞLa-1 [37], where C(λ) is 
a constant depending on the laser wavelength [38] and La is the grain size in nanometres. In Table 1, we 
have reported the values obtained using that relationship. They show that the grains on the inside 
surfaces of the stent are smaller than those on the outside of the stent, confirming our initial SEM 
observations. Raman, excited by photons at 514 nm, is mostly sensitive to sp2 sites, due to its much 
greater cross section than sp3 sites, because it does not excite the higher lying σ states. This needs a 
higher energy. So, in order to confirm the previous results, we performed Raman analysis also with a 458-
nm laser line, obtaining Id/Ig values of 1.33 and 1.29 (inner and outer surfaces, respectively) confirming a 
higher Id/Ig ratio for the inner zone. TEM measurements confirm that the ‘cauliflower’ structure is 
present also inside the film. In the same areas, we have also performed EELS analysis, from which we 
calculated the sp2/sp3 ratio using the 3-Gaussian method [39], obtaining an amount of sp3 bonds of 41 %. 
On the basis of the above results and discussion, we conclude that the stent coating has a 
homogeneous, both morphologically and chemically speaking, low-roughness surface, with very 
small grains (estimated size from 3 to 6 nm) and possesses a high amount of sp3 bonds (41 % from 
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bulk analysis).
 
 
Fig. 4 (A) Avantgarde SEM stent image (×35) after 7 days of 
implantation in a pig coronary artery and metallisation. The 
image shows a perfect total device endothelisation (98 %). 
(B) CoCr-uncoated Vision stent after 7 days of implantation 
in a pig coronary artery and metallisation. Endothelium 
uncovered stent struts are visible along the whole structure 
(percentage of endothelisation 65 %) 
 
 
 
Analysis of explanted stents 
 
Endothelisation 
 
The SEM examination of the half-stent surfaces after 7 days of implant revealed no significant presence of 
thrombotic milieu, in both stent groups. The histological analysis outlined a good endothelial coverage 
over the strut surfaces, with a carpet of cobblestone-like confluent cells. The percentage of endothelium 
coverage, measured by histomorphometric assessment, was 98 % in Avantgarde vs. 65 % in Vision (see 
Fig. 4). It is remarkable to observe that, in Vision stents, the endothelial cells growth was quite 
inhomogeneous and the lack of early endothelisation was reported even in the presence of well- 
apposed struts, where cell colonisation is usually observed. On the contrary, in Avantgarde stents 
endothelial cells also covered not completely well-apposed struts. The stent surface of the control group 
(see Fig. 5) showed a diffuse fibrin mesh entrapping red blood cells, monocytes, focal giant cells and 
small luminal adherent thrombi. In the Avantgarde group, no fibrin mesh was observed and only rare 
monocytes were scattered on the endothelial layer; thrombi were absent and the endothelium was flat 
and confluent. The endothelial cell stent coverage is found to be in continuity with the native vascular 
endothelium. This outcome in an in vivo model is in line with the observation of albumin/fibrinogen 
adsorption of Ma et al. [23] and Fedel et al. [40, 41] for DLC coatings, especially when rich in sp3 
bonds. Moreover, Fedel [40] observed that DLC coating showed a competitive and stable albumin 
passivation against fibrinogen. This condition induces a very limited adhesion and activation of 
circulating platelets and therefore does not trigger thrombotic clots, as confirmed in our experiment. 
 
Inflammatory responses 
 
Ten Avantgarde and ten Vision stents were selectively explanted at 30 days of follow-up. Stent 
expansion reached nominal diameter for both devices. The lumen of coronary arteries implanted with 
Avantgarde stents was lined by a smooth, continuous layer of endothelial cells. Histological sections 
(see Fig. 6A) showed a slight, uniform neointimal growth, free from significant inflammation and 
mainly com- posed by smooth muscle cells in a compact proteoglycan stent. 
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Fig. 5 (A) Avantgarde stent SEM image (×200). Detail of the endothelial layer. Polygonal-shaped endothelial cells are 
clearly recognisable. The cell layer is a continuum between native vessel tissue and new cells covering the metallic 
structure. Note: the visible layer detachments are due to the SEM technique. (B) CoCr-uncoated Vision 
The fibrin net adherent to the metallic structures and vessel endothelium is clearly visible. Several 
leucocytes and examples of multinucleated giant cells are present.  
 
Fig. 6 Histological 
section MOVAT (×20 
magnification). 
(A) Avantgarde stent at 30 
days. Right coronary 
artery. Thin and regular 
layer of neointimal tissue. 
(B) CoCr-uncoated 
Vision stent at 30 days 
Left descending artery. 
Neointimal growth was 
moderate but slightly 
asymmetrical.Endothelisa
tion appears complete and 
only few fibrin deposits 
around struts are 
detectable. (C) 
Avantgarde stent at 180 
days. Right coronary 
artery. Neointimal tissue 
was minimal and no signs 
of inflammation or fibrin 
and blood clots are 
present. (D) CoCr-
uncoated Vision stent at 
180 days. Left 
descending artery. 
Neointimal tissue has 
slightly increased and 
appeared asymmetrical 
and highly com- posed by 
extracellular matrix. 
Fibrin deposits have been 
reabsorbed and no 
inflammatory cells were 
detected 
 11 
 
 
 
This type of cell tends to occupy the non-endothelised areas of the stent matrix, without blood clots. The 
elastic lamina appears to be distended and compressed, as it follows the shape of the struts, but fully 
intact. 
The histological samples from the Vision stents at 30 days showed the presence of a continuous 
endothelial coating. A moderate neointimal proliferation can be seen, irregularly distributed and 
probably related to mechanical action (see Fig. 6B) caused by the asymmetric distribution of the struts 
during stent expansion. 
Ten animals were electively killed for follow-up after 180 days. These animals had been subjected 
to double implants for a total of ten Avantgarde and ten Vision stents. All the animals were in good 
clinical condition at the time of explantation, and angiography confirmed that all of the stents implanted 
were non-obstructive. The histological images of coronary arteries implanted with Avantgarde showed 
stabilised repair processes. In fact, the peak inflammatory response is generally found at 30 days after 
implant, whilst at longer follow-ups a reduction in tissue reaction can be observed. The neointimal layer 
was regular and thin (see Fig. 6C). The few smooth muscle cells present are embedded in a fibrous 
connective tissue, which appears to be well-organised in layers. There is no evidence of granulomas and 
chronic inflammatory cells. Both elastic laminae were intact, though in a number of samples they were 
slightly compressed following the morphology of the stent struts. As Vision stents are concerned, the 
neointimal layer appeared thicker and slightly asymmetrical, with occasional macrophages around the 
stent struts (see Fig. 6D). The elastic laminae were intact in most of the investigated samples, with 
few exceptions, where the internal elastic lamina was lacerated by some struts. 
Histomorphometric analysis showed in both cases a mild neointimal growth and restenotic response. 
Nonetheless, in the Avantgarde group all measured parameters were lower at 30 days. Such early 
difference between Avantgarde and Vision increased from 30 to 180 days, reaching statistical 
significance for the neointimal thickness and area values (see Table 2). This confirms the minimal 
inflammatory elicitation induced by the DLC coating of the Avantgarde. 
 
Table 2 Histomorphometric analysis results for both stents at 30 and 180 days 
      30 days     180 days 
n  Avantgarde  Vision  N  Avantgarde  Vision 
 
n number  
of  
histological  
sections  Neointimal area  
(mm2)    10  1.1±0.5  1.4±0.8  10  1.0±0.4*  1.5±0.4 
 
*p<0.05  
(neointimal  
area and 
neointimal  Neointimal  
thickness (mm)  10  0.14±0.09  0.18±0.11  10  0.10±0.05*   
0.16±0.06 
thickness  
Avantgarde 
vs. Vision)  Vessel 
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 stenosis (%)   10  24±13   27±11   10  21±8   27±6 
 
The distinct in vivo inflammatory reaction induced by the two stents, leading to slightly different 
proliferative responses, can be explained by the surface polishing and DLC coating properties. In fact, 
this particular carbon film appeared to be composed of homogenous small nanostructures and forming 
an extremely thin layer. All these characteristics preserving the mirror polished surface of the Avantgarde 
stent reduced platelet activation, the adhesion of inflammatory cells and the proliferative activation of the 
smooth muscle cells. 
 
Conclusions 
 
DLC films deposited by PVD on Co–Cr alloy stents were analysed with respect to their surface 
morphology (AFM and FESEM), chemical state (XPS), bulk sp3 content (EELS), morphology 
(TEM) and composition (Raman and EDX). Biological tests were conducted after 7 days in order to 
verify rapid endothelisation and after 30 and 180 days to investigate inflammatory responses. Our 
results showed that the iCarbofilm™ is rich in sp3 bonds (41 %) and its nano- structured surface is 
morphologically and chemically homogeneous, thanks also to its thinness which preserves the metal 
substrate’s smooth surface. These characteristics, as mentioned in several papers [23, 41], lead to a 
selective adsorption of proteins (albumin instead of fibrinogen) and to a very low platelets activation. 
The chemical and tribological characteristics recommended this new DLC coating for its extremely 
favourable haemocompatibility and non- inflammatory behaviour. The results of our study confirm 
this, with the Avantgarde DLC-coated Co–Cr stents demonstrating a more complete and homogenous 
endothelisation and effective inhibition of fibrin deposits and platelet acti- vation, reducing thrombotic 
clots. The reduced inflammatory activation of this coating resulted in complete stabilisation of 
the vessel healing within 30 days and a minimal neointimal proliferation at 180 days. 
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